Develop magnesium glycinate capsules and tablets beyond the fill-weight calculation

Set the unit and serving budgets first

Write the target elemental magnesium per serving, the number of units per serving and the accepted ingredient assay basis. An illustrative 120 mg elemental target using an ingredient assayed at 12% requires 1,000 mg of that ingredient per serving before adding other components. Across two units, that is 500 mg of magnesium ingredient per unit; it is not yet the finished fill weight.

Allocate the remaining mass and volume to other active ingredients and functional excipients. Use measured blend properties for the next trial. A neat ingredient's density is a useful starting observation, but it does not establish the packing behavior of the final formulation.

Confirm the user experience at this stage: unit dimensions, units per serving, package count and intended handling. A formula that can be manufactured may still miss the product brief.

Give capsules and tablets separate trial questions

This is a starting trial matrix, not a set of universal acceptance limits. Select methods and criteria appropriate to the product, market and any applicable compendial requirements. Avoid borrowing a time limit or strength target from an unrelated product simply because it is also a magnesium supplement.

On smaller screens, scroll the table horizontally.

Study the formulation and process together

Direct compression research has examined raw-material properties, blend composition and process settings together when predicting tablet quality. This supports a multivariable development approach; the published study does not qualify any particular magnesium glycinate grade [1].

For a first tablet screen, choose a small number of justified formulation variants and compare them across a controlled range of compression conditions. Keep the magnesium contribution fixed when that is the comparison question. Document any change in ingredient mass caused by different assays so it does not become an unnoticed second variable.

For a capsule screen, hold the capsule type and target fill constant while investigating the selected blend and dosing settings. Record startup, stable running, refills and restart behavior. Keep enough timed samples to distinguish a persistent issue from startup adjustment.

If the initial process is unsuitable, consider a formulation change or an additional processing step with the CMO. Assess its effect on composition, moisture exposure, physical behavior and subsequent testing instead of treating it as an automatic cure.

Approve a reproducible operating window

The pilot report should identify acceptable settings, observed failure modes and the evidence linking the tested units to the recorded blend. Retain samples in the intended packaging for the planned stability work. A robust initial unit does not establish unchanged performance throughout shelf life.

For U.S. dietary supplements, the manufacturer must establish relevant component, in-process and finished-product specifications. Use the pilot results to make those controls specific to the formula and process [2].

When requesting a magnesium glycinate sample, include the target serving, number of units, existing excipient constraints and intended capsule filler or tablet process. Those details make grade selection and pilot planning more useful.

Common questions